Alzheimer's & Dementia
Longitudinal clinical outcomes after amyloid clearance in aducanumab phase 3 studies
Trial in peopleInterventions
The paper
Biogen (United States); Mayo Clinic
Alzheimer's & Dementia, 1 Oct 2026
Related
medRxiv5 Oct 2026
Blood eMTBR-tau linked to Alzheimer’s tangles at autopsy
medRxiv4 Oct 2026
Tool converts plasma pTau217 values across testing platforms
medRxiv4 Oct 2026
Remote digital test flags cognitive impairment in older adults
Neurology4 Oct 2026
Plasma p-tau217 yields discordant Alzheimer results in 8.5% of adults
